Antiseptic skin agents for percutaneous procedures

Reviews in Cardiovascular Medicine

Volumn 10, Issue 4, 2009, Pages 187-193

  Lepor, Norman E ^a   Madyoon, Hooman ^a  

^a NONE

Author keywords

Percutaneously implanted devices; Procedural and surgical site infection; Skin pathogens; Skin preparation solutions

Indexed keywords

2 PROPANOL; ALCOHOL; ANTIINFECTIVE AGENT; CHLORAPREP; CHLORHEXIDINE GLUCONATE; IODINE; IODOPHOR; PHENOL; POVIDONE IODINE; PREVAIL FX; SCRUB CARE; SOLUBILIZER; UNCLASSIFIED DRUG; TOPICAL ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; ANTISEPSIS; AQUEOUS SOLUTION; ARTIFICIAL HEART PACEMAKER; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL MEMBRANE; CELL DISRUPTION; CLINICAL TRIAL; DEVICE INFECTION; DEVICE REMOVAL; DISEASE PREDISPOSITION; DNA DAMAGE; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; ENTEROCOCCUS; EPIDURAL CATHETER; FLAMMABILITY; FOOT SURGERY; GENERAL SURGERY; GENITAL SYSTEM; HAIR; HAND WASHING; HEART DEATH; HIGH RISK PATIENT; HUMAN; IMPLANTATION; INCIDENCE; INFECTION PREVENTION; INSTRUMENT STERILIZATION; JOINT PROSTHESIS; LIMB AMPUTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUCOSA; OPEN HEART SURGERY; OPERATING ROOM; OPERATION DURATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROSTHESIS INFECTION; PROTEIN DENATURATION; REVIEW; SEPSIS; SKIN SURFACE; STAPHYLOCOCCUS; SURGICAL GLOVE; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL WOUND; UROLOGIC SURGERY; VANCOMYCIN RESISTANT ENTEROCOCCUS; VAPORIZATION; WOUND INFECTION; DISINFECTION; DRUG EFFECT; HEART SURGERY; INFECTION; INFECTION CONTROL; METHODOLOGY; MICROBIOLOGY; PREOPERATIVE CARE; SKIN; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS, LOCAL; CARDIAC SURGICAL PROCEDURES; DISINFECTION; HUMANS; INFECTION CONTROL; PREOPERATIVE CARE; PROSTHESIS-RELATED INFECTIONS; SKIN; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 77649201618     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0511     Document Type: Review

References (26)

1. Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147:582-586.
2. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108:2015-2031.
3. Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg. 1996; 111:742-751.
4. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851-1859.
5. Mangram AJ, Horan TC, Pearson ML, et al; for the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20:250-280.
6. Newsom BD. Surgical wound infections: a historical review. Int J Infect Contr. 2008;4:1. doi: doi:10.3396/ijic.V4i1.002.08.
7. Digison MB. A review of anti-septic agents for preoperative skin preparation. Plast Surg Nurs. 2007;27:185-189.
8. Hibbard JS. Analyses comparing the antimicrobial activity and safety of current antiseptic agents: a review. J Infus Nurs. 2005;28:194-207.
9. Beck WC. After 2000 years, alcohol still excels. Infections in Surgery. 1985;Sept:640.
10. Weber SM, Hargunani CA, Wax MK. DuraPrep and the risk of fire during tracheostomy. Head Neck. 2006;28:649-652.
11. Data on File. St. Paul, MN: 3M Health Care.
12. Stahl JB, Morse D, Parks PJ. Resistance of antimicrobial skin preparations to saline rinse using a seeded bacteria model. Am J Infect Control. 2007;35:367-373.
13. Jacobson C, Osmon DR, Hanssen A, et al. Prevention of wound contamination using DuraPrep solution plus loban 2 drapes. Clin Orthop Relat Res. 2005;439:32-37.
14. Pinheiro SM, Couto BR, Pimenta JP, et al. Effects of iodophor skin preparation in reducing surgical site infection. Abstract presented at: 14th Annual Meeting of the Society for Healthcare Epidemiology of America. April 17-20, 2004; Philadelphia, PA.
15. Swenson BR, Hedrick TL, Metzger R, et al. Effects of preoperative skin preparation on post-operative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol. 2009;30:964-971.
16. Segal CG, Anderson JJ. Preoperative skin preparation of cardiac patients. AORN J. 2002;76:821-828.
17. Squier C, Miller T, DiLucia B, et al. Cardiac bypass surgery: intervention to decrease surgical site infections. Abstract presented at: 4th Decennial International Conference on Nosocomial and Health Care-Associated Infections in conjunction with the 10th Annual Meeting of the Society for Healthcare Epidemiology of America. March 5-9, 2000; Atlanta, GA.
18. Birnbach DJ, Meadows W, Stein DJ, et al. Comparison of povidone iodine and DuraPrep, an iodophor-in-isopropyl alcohol solution, for skin disinfection prior to epidural catheter insertion in parturients. Anesthesiology. 2003;98: 164-169.
19. Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005;87: 980-985.
20. Armstrong EP, Patrick KL, Erstad BL. Comparison of preoperative skin preparation products. Pharmacotherapy. 2001;21:345-350.
21. Roberts AJ, Wilcox K, Devineni R, et al. Skin preparations in CABG surgery: a prospective randomized trial. Comp Surg. 1995;14:741-748.
22. Khera SY, Kostyal DA, Deshmukh N. A comparison of chlorhexidine and povidone-iodine skin preparation for surgical operations. Curr Surg. 1999;56:341-343.
23. Data on file. Norcross, GA: Mölnlycke Health Care, Inc.
24. Data on file. Dublin, OH: Cardinal Health.
25. Garcia R, Mulberry G, Brady A, Hibbard JS. Comparison of ChloraPrep and Betadine as preoperative skin preparation antiseptics. Poster presented at: 40th Annual Meeting of the Infectious Disease Society of America; October 25, 2002; Chicago, IL.
26. Data on file. San Diego, CA: CareFusion, Inc.